These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
323 related items for PubMed ID: 9788618
1. Angiostatin suppresses malignant glioma growth in vivo. Kirsch M, Strasser J, Allende R, Bello L, Zhang J, Black PM. Cancer Res; 1998 Oct 15; 58(20):4654-9. PubMed ID: 9788618 [Abstract] [Full Text] [Related]
2. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA. Tanaka T, Cao Y, Folkman J, Fine HA. Cancer Res; 1998 Aug 01; 58(15):3362-9. PubMed ID: 9699667 [Abstract] [Full Text] [Related]
3. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development. Hong YK, Chung DS, Joe YA, Yang YJ, Kim KM, Park YS, Yung WK, Kang JK. Clin Cancer Res; 2000 Aug 01; 6(8):3354-60. PubMed ID: 10955823 [Abstract] [Full Text] [Related]
4. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression. Sun X, Kanwar JR, Leung E, Lehnert K, Wang D, Krissansen GW. Cancer Gene Ther; 2001 Oct 01; 8(10):719-27. PubMed ID: 11687895 [Abstract] [Full Text] [Related]
5. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Laterra J, Nam M, Rosen E, Rao JS, Lamszus K, Goldberg ID, Johnston P. Lab Invest; 1997 Apr 01; 76(4):565-77. PubMed ID: 9111517 [Abstract] [Full Text] [Related]
6. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth. O'Reilly MS. EXS; 1997 Apr 01; 79():273-94. PubMed ID: 9002223 [Abstract] [Full Text] [Related]
7. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Deryugina EI, Soroceanu L, Strongin AY. Cancer Res; 2002 Jan 15; 62(2):580-8. PubMed ID: 11809713 [Abstract] [Full Text] [Related]
8. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model. Kim CK, Joe YA, Lee SK, Kim EK, O E, Kim HK, Oh BJ, Hong SH, Hong YK. Cancer Lett; 2010 Feb 28; 288(2):251-60. PubMed ID: 19664879 [Abstract] [Full Text] [Related]
9. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene. Ishikawa H, Nakao K, Matsumoto K, Ichikawa T, Hamasaki K, Nakata K, Eguchi K. Hepatology; 2003 Mar 28; 37(3):696-704. PubMed ID: 12601367 [Abstract] [Full Text] [Related]
10. The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells. Hajitou A, Grignet C, Devy L, Berndt S, Blacher S, Deroanne CF, Bajou K, Fong T, Chiang Y, Foidart JM, Noël A. FASEB J; 2002 Nov 28; 16(13):1802-4. PubMed ID: 12354694 [Abstract] [Full Text] [Related]
11. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis. Hajitou A, Sounni NE, Devy L, Grignet-Debrus C, Lewalle JM, Li H, Deroanne CF, Lu H, Colige A, Nusgens BV, Frankenne F, Maron A, Yeh P, Perricaudet M, Chang Y, Soria C, Calberg-Bacq CM, Foidart JM, Noël A. Cancer Res; 2001 Apr 15; 61(8):3450-7. PubMed ID: 11309307 [Abstract] [Full Text] [Related]
12. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C. Cancer Res; 2003 Sep 15; 63(18):5978-91. PubMed ID: 14522925 [Abstract] [Full Text] [Related]
13. Angiostatin expression in non-small cell lung cancer. Volm M, Mattern J, Koomägi R. Clin Cancer Res; 2000 Aug 15; 6(8):3236-40. PubMed ID: 10955809 [Abstract] [Full Text] [Related]
14. Long-term expression of angiostatin suppresses metastatic liver cancer in mice. Xu R, Sun X, Tse LY, Li H, Chan PC, Xu S, Xiao W, Kung HF, Krissansen GW, Fan ST. Hepatology; 2003 Jun 15; 37(6):1451-60. PubMed ID: 12774025 [Abstract] [Full Text] [Related]
15. Endogenous growth inhibition of angiogenesis in brain tumors. Kirsch M, Allende R, Black P, Schackert G. Cancer Metastasis Rev; 2007 Dec 15; 26(3-4):469-79. PubMed ID: 17960325 [Abstract] [Full Text] [Related]
16. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340. Price A, Shi Q, Morris D, Wilcox ME, Brasher PM, Rewcastle NB, Shalinsky D, Zou H, Appelt K, Johnston RN, Yong VW, Edwards D, Forsyth P. Clin Cancer Res; 1999 Apr 15; 5(4):845-54. PubMed ID: 10213221 [Abstract] [Full Text] [Related]
17. Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. Bello L, Lucini V, Carrabba G, Giussani C, Machluf M, Pluderi M, Nikas D, Zhang J, Tomei G, Villani RM, Carroll RS, Bikfalvi A, Black PM. Cancer Res; 2001 Dec 15; 61(24):8730-6. PubMed ID: 11751392 [Abstract] [Full Text] [Related]
18. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ. Clin Cancer Res; 2000 Mar 15; 6(3):957-65. PubMed ID: 10741721 [Abstract] [Full Text] [Related]
19. Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo. Lannutti BJ, Gately ST, Quevedo ME, Soff GA, Paller AS. Cancer Res; 1997 Dec 01; 57(23):5277-80. PubMed ID: 9393749 [Abstract] [Full Text] [Related]
20. AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma. Sathornsumetee S, Hjelmeland AB, Keir ST, McLendon RE, Batt D, Ramsey T, Yusuff N, Rasheed BK, Kieran MW, Laforme A, Bigner DD, Friedman HS, Rich JN. Cancer Res; 2006 Sep 01; 66(17):8722-30. PubMed ID: 16951188 [Abstract] [Full Text] [Related] Page: [Next] [New Search]